Sfoglia per AUTORE
DREYLING M
Collezione AOU Città della Salute di Torino

  

Items : 14

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression). in Leukemia / Leukemia. 2023 Sep;37(9):1887-1894. doi: 10.1038/s41375-023-01977-y. Epub 2023 Jul 26.
2023
AOU Alessandria
AOU Città della Salute di Torino

Hoster E; Jerkeman M; Ferrero S; Ladetto M; Klapper W; Evangelista A; Unterhalt M; Rosenwald A; Kluin-Nelemans HC; Schmidt C; Jiang L; Hermine O; Dreyling M; Scheubeck G;

2023
AOU Città della Salute di Torino

Gadient S; Scheibe B; Dirnhofer S; Menter T; Ivanova VS; Cairoli A; Voegeli M; Böttcher S; Mach N; Boccomini C; Ferrero S; Mey U; Hess G; Zander T; Derenzini E; Schmidt C; Dreyling M; Schär S; Fehr M; Novak U; Eckhardt K; Zucca E; Driessen C; Renner C;

Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse. in Blood / Blood. 2022 Oct 27;140(17):1907-1916. doi: 10.1182/blood.2022015560.
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Chiappella A; Sartori R; Vitagliano O; Mannina D; Morello L; Arcari A; Nicoli P; Williams ME; Angelillo P; Marin-Niebla A; Cencini E; van Meerten T; Mocikova H; Duglosz-Danecka M; Pagani C; Auer RL; Bernard S; Infante G; Iadecola S; Muzi C; Crucitti L; Giné E; Klener P; Tucker D; Eyre TA; Cheah CY; Rusconi C; Sciarra R; Stefani PM; et alii...

Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry. in HemaSphere / Hemasphere. 2022 Apr 8;6(5):e0711. doi: 10.1097/HS9.0000000000000711. eCollection 2022 May.
2022
AOU Città della Salute di Torino

Tilch MK; Visco C; Kinda S; Hermine O; Kohn M; Besson C; Lamure S; Duléry R; Ragaini S; Eyre TA; Van Meerten T; Ohler A; Eckerle S; Dreyling M; Hess G; Giné E; Gomes da Silva M;

Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma. in The New England journal of medicine / N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3.
2022
AOU Città della Salute di Torino

Wang ML; Jurczak W; Jerkeman M; Trotman J; Zinzani PL; Belada D; Boccomini C; Flinn IW; Giri P; Goy A; Hamlin PA; Hermine O; Hernández-Rivas JÁ; Hong X; Kim SJ; Lewis D; Mishima Y; Özcan M; Perini GF; Pocock C; Song Y; Spurgeon SE; Storring JM; Walewski J; Zhu J; Qin R; Henninger T; Deshpande S; Howes A; et alii...

The EHA Research Roadmap: Malignant Lymphoid Diseases. in HemaSphere / Hemasphere. 2022 May 19;6(6):e726. doi: 10.1097/HS9.0000000000000726. eCollection 2022 Jun.
2022
AOU Città della Salute di Torino

Dreyling M; André M; Gökbuget N; Tilly H; Jerkeman M; Gribben J; Ferreri A; Morel P; Stilgenbauer S; Fox C; Maria Ribera J; Zweegman S; Aurer I; Bödör C; Burkhardt B; Buske C; Dollores Caballero M; Campo E; Chapuy B; Davies A; de Leval L; Doorduijn J; Federico M; Gaulard P; Gay F; Ghia P; Grønbæk K; Goldschmidt H; Kersten MJ; et alii...

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):188. doi: 10.3390/cancers14010188.
2021
AOU Alessandria
AOU Città della Salute di Torino

Hermine O; Vitolo U; Guarini A; Fabbri A; Patti C; Latte G; Spina M; Pascarella A; Vallisa D; Merli F; Di Renzo N; Cabras MG; Moia R; Volpetti S; Tani M; Del Giudice I; Barbero D; Ghislieri M; Drandi D; Genuardi E; Evangelista A; Passera R; Hoster E; Ferrero S; Zaccaria GM; Kluin-Nelemans HC; Cortelazzo S; Dreyling M; Ladetto M; et alii...

Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network. in HemaSphere / Hemasphere. 2020 Apr 3;4(2):e347. doi: 10.1097/HS9.0000000000000347. eCollection 2020 Apr.
2020
AOU Alessandria
AOU Città della Salute di Torino

Hermine O; Dreyling M; Cortelazzo S; Ribrag V; Eckert C; Abdo C; Callanan M; Jimenez C; Ciabatti E; Bomben R; Starza ID; Cheminant M; Villarese P; Mantoan B; Genuardi E; Ferrante M; Zaccaria G; Lhermitte L; Söhlbrandt A; Benmaad I; Alcantara M; Drandi D; Delfau-Larue MH; Pott C; Ladetto M; Ferrero S; Macintyre E;

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. in British journal of haematology / Br J Haematol. 2019 Jun;185(5):940-944. doi: 10.1111/bjh.15643. Epub 2018 Nov 8.
2019
AOU Città della Salute di Torino
AOU Novara

Vitolo U; Hoster E; Martelli M; Ruggeri M; Dreyling M; Hermine O; Loseto G; Pelosini M; Gentile M; Piazza F; Merli M; Marino D; Arcari A; Puccini B; Alvarez De Celis I; Ferrero S; Cox MC; Finolezzi E; Fabbri A; Molinari AL; Perrone T; Nassi L; Gini G; Morello L; Chiappella A; Tecchio C; Re A; Sciarra R; Hohaus S; et alii...

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Sep 1;28(9):2169-2178. doi: 10.1093/annonc/mdx289.
2017
AOU Città della Salute di Torino

Dreyling M; Morschhauser F; Bouabdallah K; Bron D; Cunningham D; Assouline SE; Verhoef G; Linton K; Thieblemont C; Vitolo U; Hiemeyer F; Giurescu M; Garcia-Vargas J; Gorbatchevsky I; Liu L; Koechert K; Peña C; Neves M; Childs BH; Zinzani PL;

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Sep;27(suppl 5):v83-v90. doi: 10.1093/annonc/mdw400.
2016
AOU Città della Salute di Torino

Dreyling M; Ghielmini M; Rule S; Salles G; Vitolo U; Ladetto M;

Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial. in Leukemia / Leukemia. 2016 Apr;30(4):984-7. doi: 10.1038/leu.2015.215. Epub 2015 Aug 5.
2016
AOU Città della Salute di Torino

Weigert O; Hiddemann W; Passera R; Ghione P; Keller U; Finke J; Trümper L; Bergmann L; Pezzutto A; Forstpointner R; Scholz CW; Pastore A; Ferrero S; Unterhalt M; Dreyling M;

The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma. in Leukemia / Leukemia. 2015 Feb;29(2):464-73. doi: 10.1038/leu.2014.223. Epub 2014 Jul 18.
2015
AOU Città della Salute di Torino

Vitolo U; Rule S; Kimby E; Le Gouill S; Ghielmini M; Geisler C; Caballero D; Corradini P; Dreger P; Robinson S; Dreyling M; Hermine O;

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2014 Jun;15(7):730-7. doi: 10.1016/S1470-2045(14)70191-3. Epub 2014 May 13.
2014
AOU Città della Salute di Torino
AOU Novara

Zanni M; Gaudiano M; Congiu A; Castellino A; Dreyling M; Botto B; Zaccaria A; Fattori PP; Salvi F; Zinzani P; Molinari AL; Liberati AM; Ladetto M; Pavone V; Spina M; Inghirami G; Baldi I; Carella AM; Franceschetti S; Chiappella A; Vitolo U; Ciccone G; Gaidano G; Rossi G;